Search Results - Endovascular Today

evt | Article | January 2021 European Supplement

COBEST Landmark Study Review

Study demonstrates long-term patency of covered stents versus bare-metal stents for aortoiliac occlusive disease.

By B. Patrice Mwipatayi, MD, MMed, MClinEd, FCS, FRACS

evt | Article | September 2018 Supplement

Combining a Drug-Coated Balloon and a Bare-Metal Stent: The REsponse Adapted Combination Therapy (REACT) Strategy

Allowing vessel response to guide appropriate treatment for SFA disease.

By Koen Deloose, MD, and B. Patrice Mwipatayi, MD, MMed, MClinEd, FCS, FRACS

evt | Article | January 2021 European Supplement

Synopsis of “A Systematic Review of Covered Balloon-Expandable Stents for Treating Aortoiliac Occlusive Disease”

Reviewing an extensive literature analysis on Advanta V12 compared with other covered balloon expandable stents for patients with complex aortoiliac lesions.

By Jean-Paul P.M. de Vries, MD, PhD

evt | News | September 28, 2011

Atrium's COBEST Trial Results Published

September 29, 2011—Atrium Medical Corporation (Hudson, NH) announced that Principal Investigator Prof.

evt | News | October 21, 2009

COBEST Preliminary 18-Month Data Presented at VIVA

October 22, 2009—The preliminary 18-month results for the COBEST (Covered Versus Balloon Expandable Stent Trial) study were presented by principal investigator Patrice Mwipatayi, FCS (SA), MMed, FRACS, at the Vascular Interventional Advances meeting in Las Vegas, Nevada.

evt | News | November 8, 2009

VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Vascular Disease

November 9, 2009—VIVA Physicians, Inc. (San Jose, CA) announced that the latest data from seven studies focused on the treatment of peripheral arterial disease were presented in the late-breaking trials session of the VIVA 2009: Vascular Interventional Advances annual meeting held on October 19 through 23 in Las Vegas, Nevada.